loading page

First in Man Use of a Leadless Pacemaker with the Evoque® Tricuspid Valve
  • +1
  • George Crossley,
  • Ansel Amaral,
  • Travis Richardson,
  • Colin M. Barker
George Crossley
Vanderbilt University Division of Cardiovascular Medicine

Corresponding Author:george.crossley@vanderbilt.edu

Author Profile
Ansel Amaral
Vanderbilt University Division of Cardiovascular Medicine
Author Profile
Travis Richardson
Vanderbilt University Division of Cardiovascular Medicine
Author Profile
Colin M. Barker
Vanderbilt University Division of Cardiovascular Medicine
Author Profile

Abstract

There is an increasing recognition of the importance of tricuspid valve disease. Surgical treatment has been less than optimal and medical therapy has poor results. Catheter based delivery has revolutionized the delivery of aortic valve prostheses and trials of catheter based tricuspid valve prostheses are ongoing. Like surgical tricuspid interventions, these procedures are associated with a significant risk of heart block, as expected from their anatomic location. The complexity of these valve prostheses makes placement of a standard transvenous system undesirable. We present a series of patients who had successful placement of a leadless pacemaker system through the valve orifice.